Skip to content
{ 2009 08 28 }

Tibotec, FDA Update Warning Label On HIV Drug’s Risk Of Severe Skin Reaction

Tibotec Therapeutics, a unit of Johnson & Johnson, “has strengthened a warning about serious skin reactions in patients treated with the company’s HIV drug Intelence,” the FDA and the company said on Wednesday, Reuters reports.

Bookmark and Share
Posted by SkinDoc on Friday, August 28, 2009, at 9:41 am. Filed under Skin Care News. Tagged , , , , , , , , , . Follow any responses to this post with its comments RSS feed. Both comments and trackbacks are currently closed.